MGTX News and Press, MeiraGTx Holdings plc From 02/27/19

Gainers:  BroadVision (NASDAQ: BVSN ) +36% . Frontier Communications (NYSE: FTR ) +26% . Tandem Diabetes Care (NASDAQ: TNDM ) +26% . Sea Limited (NYSE: SE ) +25% . Realm Therapeutics Plc ( RLM ) +16% . MeiraGTx Holdings plc (NASDAQ: MGTX ) +23% . Summit Therapeutics plc (NASDAQ:...

LONDON and NEW YORK, Feb. 27, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it has agreed to sell approximately 5.8 million ordinary shares at a price of $13.80 per share. MeiraGTx antici...

LONDON and NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the appointment of Dr. Martin Indyk to its Board of Directors. Martin Indyk is an American diplomat who...

In (yet another) statement , FDA Commission Scott Gottlieb, M.D. announces the issuance of final updated guidance for gene therapy and cell therapy developers. More news on: Abeona Therapeutics Inc., Bellicum Pharmaceuticals, ZIOPHARM Oncology, Inc., Healthcare stocks news, Read more ...

The following slide deck was published by MeiraGTx Holdings plc in conjunction with this Read more ...

Axovant Sciences Ltd ( AXON ) is approaching two key catalysts which may attract the attention of the markets. When I last wrote about the company , I noted that I didn't like the decisions being made at AXON. Throughout 2019 we may begin to see if the company's risky decision, to pivot into ...

LONDON and NEW YORK, Feb. 05, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer of MeiraGTx, will present at the BIO ...

Gainers:  Fortress Biotech (NASDAQ: FBIO ) +41% . MeiraGTx Holdings (NASDAQ: MGTX ) +29% . Eldorado Gold (NYSE: EGO ) +23% . Avon Products (NYSE: AVP ) +22% . Silicom (NASDAQ: SILC ) +20% . Onconova Therapeutics (NASDAQ: ONTX ) +20% . 1-800-FLOWERS.COM (NASDAQ: FLWS ) +19% . Tu...

MeiraGTx (NASDAQ: MGTX ) inks a collaboration agreement with Johnson & Johnson (NYSE: JNJ ) unit Janssen Pharmaceutical to develop and commercialize gene therapies for the treatment of inherited retinal diseases (IRDs), including MGTX's candidates for achromatopsia (partial or total ab...

-- Conference call and webcast today, January 31, 2019 at 8:30 a.m. EST -- MeiraGTx to receive $100 million cash upfront payment upon closing -- MeiraGTx to receive 20% net sales royalties and additional potential future milestone payments -- Janssen Pharmaceuticals, Inc. to fund al...